NO20011654D0 - Benzamidderivater som trombininhibitorer - Google Patents

Benzamidderivater som trombininhibitorer

Info

Publication number
NO20011654D0
NO20011654D0 NO20011654A NO20011654A NO20011654D0 NO 20011654 D0 NO20011654 D0 NO 20011654D0 NO 20011654 A NO20011654 A NO 20011654A NO 20011654 A NO20011654 A NO 20011654A NO 20011654 D0 NO20011654 D0 NO 20011654D0
Authority
NO
Norway
Prior art keywords
thrombin inhibitors
benzamide derivatives
benzamide
derivatives
thrombin
Prior art date
Application number
NO20011654A
Other languages
English (en)
Other versions
NO20011654L (no
Inventor
Henry Anderson Kelly
Martin Pass
David Neil Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20011654D0 publication Critical patent/NO20011654D0/no
Publication of NO20011654L publication Critical patent/NO20011654L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO20011654A 1998-10-03 2001-04-02 Benzamidderivater som trombininhibitorer NO20011654L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9821483.6A GB9821483D0 (en) 1998-10-03 1998-10-03 Chemical compounds
PCT/EP1999/007194 WO2000020394A1 (en) 1998-10-03 1999-09-30 Benzamide derivatives as thrombin inhibitors

Publications (2)

Publication Number Publication Date
NO20011654D0 true NO20011654D0 (no) 2001-04-02
NO20011654L NO20011654L (no) 2001-05-30

Family

ID=10839873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011654A NO20011654L (no) 1998-10-03 2001-04-02 Benzamidderivater som trombininhibitorer

Country Status (21)

Country Link
US (2) US6441008B1 (no)
EP (1) EP1117644A1 (no)
JP (1) JP3457281B2 (no)
KR (1) KR20010075546A (no)
CN (1) CN1328548A (no)
AR (1) AR023332A1 (no)
AU (1) AU758007B2 (no)
BR (1) BR9914267A (no)
CA (1) CA2345997A1 (no)
CO (1) CO5140085A1 (no)
CZ (1) CZ20011216A3 (no)
GB (1) GB9821483D0 (no)
HU (1) HUP0103744A3 (no)
IL (1) IL142301A0 (no)
MA (1) MA26695A1 (no)
NO (1) NO20011654L (no)
NZ (1) NZ510839A (no)
PE (1) PE20001059A1 (no)
PL (1) PL347152A1 (no)
TR (1) TR200100906T2 (no)
WO (1) WO2000020394A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117144D0 (en) * 2001-07-13 2001-09-05 Glaxo Group Ltd Process
EP1637141B1 (en) 2004-09-21 2011-11-16 Trobio AB Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease
AU2005336535B2 (en) * 2005-09-22 2012-05-24 Trobio Ab Stabilized protease composition
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW257757B (no) 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
IL109144A (en) 1993-03-29 2000-02-29 Zeneca Ltd Glycoprotein IIB/IIIA inhibiting 4-pyridylamino heterocyclic derivatives process for their preparation and pharmaceutical compositions containing them
GB9525620D0 (en) * 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP2002526531A (ja) 2002-08-20
HUP0103744A3 (en) 2002-03-28
MA26695A1 (fr) 2004-12-20
CZ20011216A3 (cs) 2001-09-12
BR9914267A (pt) 2001-07-03
AU758007B2 (en) 2003-03-13
US20020169189A1 (en) 2002-11-14
KR20010075546A (ko) 2001-08-09
IL142301A0 (en) 2002-03-10
AU6467099A (en) 2000-04-26
CA2345997A1 (en) 2000-04-13
JP3457281B2 (ja) 2003-10-14
NO20011654L (no) 2001-05-30
PE20001059A1 (es) 2000-10-23
CN1328548A (zh) 2001-12-26
AR023332A1 (es) 2002-09-04
US6670381B2 (en) 2003-12-30
PL347152A1 (en) 2002-03-25
TR200100906T2 (tr) 2001-07-23
CO5140085A1 (es) 2002-03-22
NZ510839A (en) 2003-08-29
WO2000020394A1 (en) 2000-04-13
GB9821483D0 (en) 1998-11-25
EP1117644A1 (en) 2001-07-25
US6441008B1 (en) 2002-08-27
HUP0103744A2 (hu) 2002-02-28

Similar Documents

Publication Publication Date Title
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO20030867D0 (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
NO20014483D0 (no) Aminderivater som proteaseinhibitorer
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO20010686D0 (no) Hydroksypipecolathydroksaminsyrederivater som MMP inhibitorer
NO20031540D0 (no) Benzamidforbindelser som Apo-B-sekresjonsinhibitorer
NO20002958D0 (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
NO20012980D0 (no) Proteaseinhibitorer
DK1460066T3 (da) Piperazinforbindelse som tachykinin-inhibitorer
NO20015065D0 (no) Pyrazolobenzodiazepiner som CDK2-inhibitorer
DK1097127T3 (da) Diacylhydrazinderivater som integrininhibitorer
ATE460424T1 (de) Factor viia inhibitore
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
NO20004696L (no) Kinoloner som serinproteaseinhibitorer
NO20021407D0 (no) Bifenylderivater anvendt som NHE-3-inhibitorer
NO994103D0 (no) Reverse hydroksamatderivater som metallproteaseinhibitorer
NO20001924L (no) Isoquinoliner som urokinase-inhibitorer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NO20003814D0 (no) Trombininhibitorer
NO20014875D0 (no) Promedikamenter for trombin inhibitorer
NO20021959L (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
NO991994D0 (no) Substituerte 4-bifenyl-4-hydroksysm°rsyrederivater som matriks-metalloproteaseinhibitorer
NO20005301D0 (no) Pyrrolidiner som inhibitorer av neuraminidaser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application